Creso Pharma Limited

Creso Pharma Limited

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditionsNEDLANDS, Australia, Feb. 8, 2023 --Β Creso Pharma LimitedΒ (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Scie... Read More...

Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc

Halucenex a key strategic asset for proposed merger between Red Light Holland and Creso Pharma to create The HighBrid LabToronto, Ontario--(Newsfile Corp. - July 15, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growt... Read More...

Red Light Holland to Host a Live Stream on the Company’s Social Media Handles, Including www.youtube.com/redlightholland at 8:30 am Eastern Time on Thursday, June 17th to Discuss Previously Announced Merger with Creso Pharma and Formation of the HighBrid Lab(TM)

Todd Shapiro, Bruce Linton, William Lay and Adam Blumenthal to PresentToronto, Ontario--(Newsfile Corp. - June 16, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland") is pleased to announce that it will host a live stream with a supplemental presentation alongside Creso Pharma Limited (ASX: CPH) ... Read More...